Giovanni Rizzo PhD, MBA is Venture Partner at Indaco Venture Partners
Dr. Giovanni Rizzo received his Biology degree at the “La Sapienza” University of Rome, his PhD in Oncology and his specialization in microbiology at the University of Perugia, Italy, his post-graduate qualification in preclinical and clinical development of drugs from University “La Bicocca” Milano and his Executive Master in Business Administration (EMBA) at the HULT International Business School, London. He holds an honorary research position at the University College London (UCL) in the Institute of Liver and Digestive Health (ILDH) and is invited professor at the Milano Bicocca University, Master in Preclinical and clinical development of drugs.
Dr. Rizzo brings an extensive experience (over 20 years) in drug discovery and development and some experience in medical device development
He was head of biology of Intercept Pharmaceuticals Inc.; Consultant at Index Ventures (now MediXci), a venture capital firm; CEO of iDNA Ltd, a drug discovery service company; Vice President of Yaqrit Ltd, a spin off company of the University College London, member of board of directors and Chief of Innovation Division of Zcube Zambon group (pharma company).
Dr. Rizzo is an entrepreneur and an investor himself of the London Business Angels (LBA) association; he is board member of the Italian Angels for Biotech, Italy and he sits as board member of few companies.